This in vitro potency translated into in vivo efficacy, where a single dose of the BsADC (5 mg/kg) achieved 85% tumor growth inhibition in a BT-474 xenograft model, compared to 45% inhibition by the conventional ADC at the same dose
Therefore, in liver-specific IGF-1-deficient mouse models, circulating IGF-1 levels are reduced to 30 mL) (43)
Tirzepatide is a dual GIP and GLP-1 receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in adults with obesity or overweight with weight-related comorbidities
149 Upregulation of THOC2 and THOC5 protein expression can promote the THOC-mediated spliced mRNA efflux, leading to increased synthesis of NANOG and SOX2 proteins
Sustained Weight Loss (Weeks 12+) Plateau Phase and Importance of Patience As individuals progress beyond the initial weeks of treatment, they may experience a plateau in weight loss
Cancer 20 , 437454 (2020)